3 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Cancer Vaccine development for Hepatocellular Carcinoma (HepaVac)
Date du début: 1 sept. 2013, Date de fin: 31 août 2018,
"Hepatocellular carcinoma (HCC) is the most common primary liver cancer and accounts for about 6% of all new cancer cases worldwide. Given the lack of available effective treatments, the overall prognosis for HCC patients is poor, with a dismal 5-year survival of 5-6%. The main goal of this proposal is to develop a therapeutic cancer vaccine aiming at improving clinical outcome in early-stage HCC ...
Voir le projet
10
Participants partenaires
TERMINÉ
Resveratrol-induced molecular markers in cancer and progenitor cells proliferation (Resveratrol roles)
Date du début: 1 janv. 2011, Date de fin: 31 déc. 2014,
Many genes that have been shown to cause cancer were originally identified because of their role in embryonic development and in the postnatal control of cell growth and differentiation. The similarities between cancer and development are evident on many levels. Microscopically, cancerous tissues frequently appear as undifferentiated masses, with some tumor types exhibiting embryonic tissue organ ...
Voir le projet
1
Participant partenaire
TERMINÉ
Next Generation HIV-1 Immunogens inducing broadly reactive Neutralising antibodies (NGIN)
Date du début: 1 févr. 2008, Date de fin: 31 juil. 2012,
"The elicitation of broadly neutralising antibodies (Nab) remains the primary and most challenging goal in HIV-1 vaccine development. Although a few anti-HIV-1 monoclonal antibodies with broadly neutralising capability have been isolated from infected individuals, none of the immunization strategies thus far explored has proven effective in inducing similar antibodies. Objective of this applicatio ...
Voir le projet